6th Annual Residential Substance Abuse Treatment Conference

Slides:



Advertisements
Similar presentations
Mady Chalk, PhD., MSW Treatment Research Institute November, 2013.
Advertisements

Personal & Policy Perspectives on the Collegiate Recovery Movement Peter Gaumond Chief, Recovery Branch Office of National Drug Control Policy (ONDCP)
Nora D. Volkow, M.D. Director National Institute on Drug Abuse Nora D. Volkow, M.D. Director National Institute on Drug Abuse What Do We Know? Drug Abuse.
Translating Research to Practice in Treating Substance Use Disorders Richard Rawson, Ph. D. UCLA Drug Abuse Research Center Matrix Institute on Addictions.
TM Centers for Disease Control and Prevention National Center for Injury Prevention and Control Centers for Disease Control and Prevention National Center.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2011.
Recovery Housing and The National Drug Control Strategy David K. Mineta Deputy Director, Demand Reduction Office of National Drug Control Policy (ONDCP)
John R. Kasich, Governor Tracy J. Plouck, Director Andrea Boxill, Deputy Director Andrea Boxill, Deputy Director Governor’s Cabinet Opiate Action Team.
P RESCRIPTION D RUG A BUSE : T HE N ATIONAL P OLICY P ERSPECTIVE Michael Gottlieb, National HIDTA Director Office of National Drug Control Policy May 7,
Understanding Drug Abuse and Addiction: What Science Says Developed by the National Institute on Drug Abuse (NIDA) National Institutes of Health Bethesda,
Recovery Oriented Systems of Care in Minnesota
1 Mental Health and Substance Abuse Services Division Association of Substance Abuse Providers Mike Maples October 5, 2011.
Responding to Drug Abuse and Addiction: What Science Says Developed by the National Institute on Drug Abuse (NIDA) National Institutes of Health Bethesda,
1 Alcohol and Substance Abuse Council of Jefferson County, Inc. 167 Polk Street, Suite 320 Watertown, New York Voice: ; Fax: ;
Recovery Support Services and Client Outcomes: What do the Data Tell Us? Recovery Community Services Program Grantee Meeting December 14, 2007.
Building a Common Vision for Recovery in America Michael T. Flaherty, Ph.D. Pittsburgh, Pennsylvania White House Compassion in Action Roundtable September.
Understanding Drug Abuse and Addiction: What Science Says Developed by the National Institute on Drug Abuse (NIDA) National Institutes of Health Bethesda,
Introduction Results and Conclusions On demographic variables, analyses revealed that ATR clients were more likely to be Hispanic and employed, whereas.
Opiate Management Douglas Keehn DO Adjunct Assistant Clinical Professor University Wisconsin Board Certified Anesthesia & Pain Management.
A 21st Century Drug Policy : Implications for Research and Practice
Understanding Drug Abuse and Addiction: What Science Says Developed by the National Institute on Drug Abuse (NIDA) National Institutes of Health Bethesda,
1 Use of Pharmacotherapies by Substance Abuse Treatment Facilities November 2007 Cathie E. Alderks, PhD Substance Abuse and Mental Health Services Administration.
Substance Use Disorders and Overdose: The Basics Public Curricula – Essential Knowledge for Families and Communities Core Component.
The Prescription Opioid & Heroin Crisis: Addiction & Medication Assisted Treatment Andrew Kolodny, M.D. Chief Medical Officer, Phoenix House Foundation.
Substance Exposed Newborns: Addressing Substance Use Disorder
Medication Assisted Treatment
Psychosocial Combined with Agonist Maintenance Treatments versus Agonist Maintenance Treatments Alone for Treatment of Opioid Dependence (Review) Amato,
State Targeted Response to Opioid Crisis
Initiatives Toward A Public Health Approach
OPIOID EPIDEMIC.
screening, brief intervention and referral to treatment
Wireless Access SSID: cwag2017
US Census Data Ortman, Jennifer M., Victoria A. Velkoff, and Howard Hogan. An Aging Nation: The Older Population in the United States, Current Population.
Jessica E. Bates, Pharm.D. PGY-1 Pharmacy Resident
Drugs and Neuron Communication
Integrating Care Through Partnerships – Missouri’s Experience
5th Annual Empowering Local Leadership Conference
10th Annual Susan Li Conference
Nebraska Prescription Drug Overdose Prevention Program Efforts
Medication-Assisted Therapy at Coleman Profession Services
COLLECTIVE IMPACT APPROACH TO ADDRESSING
Department of Psychiatry Section of Population Behavioral Health
Addressing the Opioid Epidemic
McLean Hospital Division of Alcohol and Drug Abuse
Adolescent Chemical Dependency
Opiates: The Big Picture
Nick Szubiak, MSW, LCSW Director, Clinical Excellence in Addictions
Addiction and the Opioid Crisis: HHS Update
MEDICATION ASSISTED TREATMENT for OPIATE ADDICTION
The Epidemiology of Injury and Science of Injury Prevention
THR Behavioral Health Service Line
Jonathan Mermin, MD, MPH RADM, USPHS
CSAP Programs and Resources to Support SAMHSA’s Prevention Efforts
Treatments for Addiction
Mitigating the Safety Risks of Drugs With a Focus on Opioids: Are Risk Evaluation and Mitigation Strategies the Answer?  Marta J. Brooks, PharmD  Mayo.
Peaceful Spirit Treatment Center
Primary Prevention in the Time of the Opioid Epidemic
Behavioral Health PRC Results
Pain Management and Substance Use Disorders: JCPP Strategic Session
Asian American Mental Health Status and Care
Impact of Policy and Regulatory Responses to the Opioid Epidemic on the Care of People with Serious Illness Hemi Tewarson, Director, Health Division National.
Sara Olack, MD, PhD Cecilia Lau, MD Advisor: Jane Gagliardi, MD
Figure 1. National Drug Overdose Deaths Number Among All Ages, by Gender, Figure 1. National Drug Overdose Deaths—Number Among All Ages, by Gender,
Addiction Treatment Program North Canyon Medical Center
Medication Assisted Treatment: Changing the Trajectory of the Opioid Epidemic
A Training For Multidisciplinary Addiction Professionals
Substance Use Prevention for Young Adults and Higher Education
The Judicial Branch’s Response to the Opioid Crisis
Strategic Initiatives to Address Opioid Overdose & Addiction
Can be personalized to individual group needs.
Presentation transcript:

6th Annual Residential Substance Abuse Treatment Conference Richard J. Baum Acting Director Office of National Drug Control Policy August 1, 2017

Office of National Drug Control Policy 5/9/2017 Drug Poisoning Deaths Continue to Climb Deaths Involving Opioid Analgesics, Cocaine, Heroin, and Psychostimulants % CHANGE 2010 to 2015 +31% + 328% + 62% + 208% All drug poisoning (overdose) deaths include unintentional (accidental), intentional (suicide or homicide), and undetermined intent. Of the deaths that specify a drug involved, the most commonly mentioned is a class of prescription painkillers called opioid analgesics. For several years now, there have been more deaths involving opioid analgesics than heroin or cocaine combined. AND these figures are likely underestimates because death certificates do not always specify the drugs involved. Note: Not all drug poisoning deaths specify the drug(s) involved, and a death may involve more than one specific substance. The rise in 2005-2006 in opioid deaths is related to non-pharmaceutical fentanyl (see http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5729a1.htm). Source: Centers for Disease Control and Prevention, National Center for Health Statistics. Multiple Cause of Death 1999-2015 on CDC WONDER Online Database, released 2016. Data were extracted by ONDCP from http://wonder.cdc.gov/mcd-icd10.html on December 8, 2016. 12/2016

8,428,000 Needing Drug Treatment at a Specialty Facility Need/Receipt of Drug Treatment at a Specialty Facility Among Persons Aged 12 or Older: 2015 Felt They Needed Treatment and Did Not Make an Effort (321,000) Did Not Feel They Needed Treatment (6,369,000) 4% Felt They Needed Treatment and Did Make an Effort (197,000) 2% 76% 18% Many people do not voluntarily seek treatment, even if they would benefit from it. Received Specialty Treatment (1,541,000) 8,428,000 Needing Drug Treatment at a Specialty Facility Source: SAMHSA, 2015 National Survey on Drug Use and Health (September 2016). 9/2016

Pathways to Treatment Healthcare providers Community health centers Police and first responders Credit: McGraw-Hill

Workforce Challenges Medical field Counseling Drug Court professionals Doctors Physician’s assistants Nurses Counseling Peer counselors Recovery coaches Case managers Drug Court professionals

The Power of Recovery People in recovery are great advocates and resources Credit: Recovery Communities of North Carolina

Credit: The Associated Press Opioid and Drug Abuse Listening Session Cabinet Room, The White House March 29, 2017 Credit: The Associated Press

Treatment in Criminal Justice System The findings from a NIDA- and Department of Veterans Affairs (VA) Health Services Research and Development Service-supported analysis of data on treatment outcomes affirm the results of shorter term studies that have shown similar therapeutic outcomes for voluntary and legally mandated patients. The new study also included an important, but largely unstudied, comparison group: people who had been in court, but were not mandated to enter treatment. Regardless of their impetus for participating in drug treatment—internal drive or external pressure—men had similar outcomes in the long term. At the end of treatment, all three groups of patients demonstrated enhanced coping skills and expressed more confidence that they could resist alcohol or drugs in high-risk situations. Symptoms of psychological distress improved for participants in all groups. At the 1-year followup, larger proportions of JSI-M participants reported abstinence, successful moderation in their use of alcohol, and freedom from drug-related consequences . Kelly, J.F.; Finney, J.W.; and Moos, R. Substance use disorder patients who are mandated to treatment: Characteristics, treatment process, and 1- and 5-year outcomes. Journal of Substance Abuse Treatment 28(3):213-223, 2005

Treatment Referral Source for All Admissions: 2014 School (educational) (0.7%) Employer/EAP (0.4%) Other health care provider (7.0%) Substance abuse care provider (10.7%) Self or individual (37.5%) Other community referral (10.8%) Source: SAMHSA, Center for Behavioral Health Statistics and Quality. Treatment Episode Data Set:2004-2014, Detailed Tables, Table 2.6B (May 2016). Court/criminal justice system (32.9%) 1.614 Million Treatment Admissions for a Drug or Alcohol Problem Source: SAMHSA, Center for Behavioral Health Statistics and Quality. Treatment Episode Data Set:2004-2014, Detailed Tables, Table 2.6B (May 2016). 2/2017

Medication-Assisted Treatment Is Effective Patients taking methadone with counseling were over four times more likely to stay in treatment Treatment with methadone significantly improves treatment outcomes alone and when added to counseling Treatment with buprenorphine results in a 75-80 percent reduction of patients testing positive for opioids Volkow, N. (2016). What Science tells us About Opioid Abuse and Addiction. Testimony to the Senate Judiciary Committee. National Institute on Drug Abuse. Mattick, R. P. et al. (2014). Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst. Rev. 2, CD002207. Mattick, R. Pet al. (2009). Cochrane Database of Systematic Reviews (ed. The Cochrane Collaboration) (John Wiley & Sons, Ltd). at http://doi.wiley.com/10.1002/14651858.CD002209.pub2.

Follow ONDCP on Twitter